Trial Profile
Single-center , double-blind, single-dose, 2-treatment period, crossover study to evaluate the pharmacokinetics and safety profiles of SD-1077 and L-DOPA, each in combination with an oral dose of Carbidopa in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Jul 2018
Price :
$35
*
At a glance
- Drugs Levodopa deuterated (Primary) ; Carbidopa; Levodopa
- Indications Parkinson's disease
- Focus Adverse reactions; Pharmacokinetics
- 21 Jul 2018 New trial record
- 29 Jun 2018 Results published in the British Journal of Clinical Pharmacology